Largest NASDAQ Health Care Companies By Total Asset

Total Asset
Total AssetEfficiencyMarket RiskExp Return
1SNY Sanofi ADR
126.46 B
 0.23 
 1.23 
 0.29 
2AZN AstraZeneca PLC ADR
101.12 B
(0.02)
 1.18 
(0.03)
3AMGN Amgen Inc
97.15 B
 0.09 
 1.23 
 0.11 
4GILD Gilead Sciences
62.12 B
 0.25 
 1.32 
 0.32 
5VTRS Viatris
47.69 B
 0.10 
 1.88 
 0.18 
6GMAB Genmab AS
35.29 B
(0.05)
 1.78 
(0.09)
7REGN Regeneron Pharmaceuticals
33.08 B
 0.03 
 1.40 
 0.04 
8GEHC GE HealthCare Technologies
32.45 B
 0.18 
 1.42 
 0.26 
9BIIB Biogen Inc
26.84 B
(0.14)
 1.60 
(0.22)
10BNTX BioNTech SE
23.01 B
 0.16 
 3.44 
 0.56 
11VRTX Vertex Pharmaceuticals
22.73 B
(0.03)
 1.24 
(0.04)
12GRFS Grifols SA ADR
21.45 B
 0.10 
 4.35 
 0.44 
13MRNA Moderna
18.43 B
(0.24)
 3.96 
(0.94)
14ICLR ICON PLC
16.99 B
(0.04)
 1.91 
(0.07)
15RPRX Royalty Pharma Plc
16.38 B
 0.06 
 1.36 
 0.09 
16ISRG Intuitive Surgical
15.44 B
 0.09 
 1.80 
 0.16 
17COO The Cooper Companies,
11.66 B
 0.20 
 1.83 
 0.37 
18JAZZ Jazz Pharmaceuticals PLC
11.39 B
 0.02 
 1.64 
 0.04 
19HSIC Henry Schein
10.57 B
 0.09 
 1.87 
 0.16 
20ILMN Illumina
10.11 B
 0.14 
 2.45 
 0.34 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.